p.97 抽出テキスト
776. Cho IJ, Lee SE, Jeong H, Chang HJ. Determinants of clinical outcomes in patients with mixed mitral valve disease. Echocardiography 2020;37:1164–70. https://doi.org/10. 1111/echo.14673 777. Pawade T, Sheth T, Guzzetti E, Dweck Marc R, Clavel M-A. Why and how to measure aortic valve calcification in patients with aortic stenosis. JACC Cardiovasc Imaging 2019; 12:1835–48. https://doi.org/10.1016/j.jcmg.2019.01.045 779. Bandera F, Generati G, Pellegrino M, Garatti A, Labate V, Alfonzetti E, et al. Mitral regurgitation in heart failure: insights from CPET combined with exercise echocardiography. Eur Heart J Cardiovasc Imaging 2017;18:296–303. https://doi.org/10.1093/ehjci/ jew096 780. Bissessor N, Shanahan L, Wee YS, Stewart R, Lowe B, Kerr A, et al. The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve disease. Congest Heart Fail 2010;16:50–4. https://doi.org/10.1111/j.1751-7133.2009. 00132.x 781. Myerson SG. CMR in evaluating valvular heart disease: diagnosis, severity, and outcomes. JACC Cardiovasc Imaging 2021;14:2020–32. https://doi.org/10.1016/j.jcmg. 2020.09.029 782. Grafton G, Cascino TM, Perry D, Ashur C, Koelling TM. Resting oxygen consumption and heart failure: importance of measurement for determination of cardiac output with the use of the Fick principle. J Card Fail 2020;26:664–72. https://doi.org/10. 1016/j.cardfail.2019.02.004 783. Singh AD, Mian A, Devasenapathy N, Guyatt G, Karthikeyan G. Percutaneous mitral commissurotomy versus surgical commissurotomy for rheumatic mitral stenosis: a systematic review and meta-analysis of randomised controlled trials. Heart 2020; 106:1094–101. https://doi.org/10.1136/heartjnl-2019-315906 784. Winter MP, Bartko PE, Krickl A, Gatterer C, Donà C, Nitsche C, et al. Adaptive development of concomitant secondary mitral and tricuspid regurgitation after transcatheter aortic valve replacement. Eur Heart J Cardiovasc Imaging 2021;22:1045–53. https://doi.org/10.1093/ehjci/jeaa106 785. Khan F, Okuno T, Malebranche D, Lanz J, Praz F, Stortecky S, et al. Transcatheter aortic valve replacement in patients with multivalvular heart disease. JACC Cardiovasc Interv 2020;13:1503–14. https://doi.org/10.1016/j.jcin.2020.03.052 786. Adamo M, Pagnesi M, Ghizzoni G, Estévez-Loureiro R, Raposeiras-Roubin S, Tomasoni D, et al. Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality. Eur J Heart Fail 2022;24:2175–84. https://doi.org/10.1002/ejhf.2637 787. Kavsur R, Iliadis C, Spieker M, Brachtendorf BM, Tiyerili V, Metze C, et al. Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair. EuroIntervention 2021;17:827–34. https://doi.org/10. 4244/eij-d-20-01094 788. Mehr M, Karam N, Taramasso M, Ouarrak T, Schneider S, Lurz P, et al. Combined tricuspid and mitral versus isolated mitral valve repair for severe MR and TR: an analysis from the TriValve and TRAMI registries. JACC Cardiovasc Interv 2020;13:543–50. https://doi.org/10.1016/j.jcin.2019.10.023 789. Besler C, Blazek S, Rommel KP, Noack T, von Roeder M, Luecke C, et al. Combined mitral and tricuspid versus isolated mitral valve transcatheter edge-to-edge repair in patients with symptomatic valve regurgitation at high surgical risk. JACC Cardiovasc Interv 2018;11:1142–51. https://doi.org/10.1016/j.jcin.2018.04.010 790. Egbe AC, Luis SA, Padang R, Warnes CA. Outcomes in moderate mixed aortic valve disease: is it time for a paradigm shift? J Am Coll Cardiol 2016;67:2321–9. https://doi.org/ 10.1016/j.jacc.2016.03.509 791. Egbe AC, Poterucha JT, Warnes CA. Mixed aortic valve disease: midterm outcome and predictors of adverse events. Eur Heart J 2016;37:2671–8. https://doi.org/10.1093/ eurheartj/ehw079 792. Zilberszac R, Gabriel H, Schemper M, Zahler D, Czerny M, Maurer G, et al. Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol 2013;61: 1489–95. https://doi.org/10.1016/j.jacc.2012.11.070 793. Isaza N, Desai MY, Kapadia SR, Krishnaswamy A, Rodriguez LL, Grimm RA, et al. Long-term outcomes in patients with mixed aortic valve disease and preserved left ventricular ejection fraction. J Am Heart Assoc 2020;9:e014591. https://doi.org/10. 1161/jaha.119.014591 794. Saijo Y, Isaza N, Conic JZ, Desai MY, Johnston D, Roselli EE, et al. Left ventricular longitudinal strain in characterization and outcome assessment of mixed aortic valve disease phenotypes. JACC Cardiovasc Imaging 2021;14:1324–34. https://doi.org/10.1016/j. jcmg.2021.01.020 795. Bernard J, Jean G, Bienjonetti-Boudreau D, Jacques F, Tastet L, Salaun E, et al. Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease. Open Heart 2023;10:e002361. https://doi.org/10.1136/openhrt-2023- 002361 796. Onishi H, Naganuma T, Izumo M, Ouchi T, Yuki H, Mitomo S, et al. Prognostic relevance of B-type natriuretic peptide in patients with moderate mixed aortic valve disease. ESC Heart Fail 2022;9:2474–83. https://doi.org/10.1002/ehf2.13946 797. Carpentier AF, Pellerin M, Fuzellier JF, Relland JY. Extensive calcification of the mitral valve anulus: pathology and surgical management. J Thorac Cardiovasc Surg 1996;111:718–29; discussion 729–730. https://doi.org/10.1016/s0022-5223(96) 70332-x 798. World Health Organization. Life Expectancy at Birth. https://www.who.int/ data/gho/indicator-metadata-registry/imr-details/3131 (28 March 2025, date last accessed). 799. Johansson I, Benz AP, Kovalova T, Balasubramanian K, Fukakusa B, Lynn MJ, et al. Outcomes of patients with a mechanical heart valve and poor anticoagulation control on warfarin. Thromb Haemost 2024;124:613–24. https://doi.org/10.1055/s-0043- 1777827 800. Persson M, Glaser N, Nilsson J, Friberg O, Franco-Cereceda A, Sartipy U. Comparison of long-term performance of bioprosthetic aortic valves in Sweden from 2003 to 2018. JAMA Netw Open 2022;5:e220962. https://doi.org/10.1001/jamanetworkopen.2022. 0962 801. Jiang Y, Wang S, Bian J, Chen S, Shao Y. Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults: a systematic review and meta-analysis. J Cardiovasc Dev Dis 2023;10:90. https://doi.org/10.3390/jcdd10020090 802. Kim MS, Kim HR, Lee SH, Lee S, Joo HC. Aortic valve replacement in patients aged 50 to 69 years: analysis using Korean National Big Data. J Card Surg 2022;37:3623–30. https://doi.org/10.1111/jocs.16908 803. Vogt F, Santarpino G, Fujita B, Frerker C, Bauer T, Beckmann A, et al. Surgical aortic valve replacement in patients aged 50–69 years—insights from the German Aortic Valve Registry (GARY). Eur J Cardiothorac Surg 2022;62:ezac286. https://doi.org/10. 1093/ejcts/ezac286 804. Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years. Eur Heart J 2016;37:2658–67. https://doi.org/10.1093/eurheartj/ehv580 805. Kiyose AT, Suzumura EA, Laranjeira L, Buehler AM, Santo JAE, Berwanger O, et al. Comparison of biological and mechanical prostheses for heart valve surgery: a systematic review of randomized controlled trials. Arq Bras Cardiol 2019;112:292–301. https:// doi.org/10.5935/abc.20180272 806. Bouhout I, Ghoneim A, Poirier N, Cartier R, Demers P, Perrault LP, et al. Impact of the learning curve on early outcomes following the Ross procedure. Can J Cardiol 2017;33: 493–500. https://doi.org/10.1016/j.cjca.2016.11.014 807. Tasoudis PT, Varvoglis DN, Vitkos E, Mylonas KS, Sá MP, Ikonomidis JS, et al. Mechanical versus bioprosthetic valve for aortic valve replacement: systematic review and meta-analysis of reconstructed individual participant data. Eur J Cardiothorac Surg 2022;62:ezac268. https://doi.org/10.1093/ejcts/ezac268 808. Leviner DB, Witberg G, Levi A, Landes U, Schwartz N, Shiran A, et al. Mechanical vs bioprosthetic aortic valve replacement in patients younger than 70 years of age: a hazard ratio meta-analysis. Can J Cardiol 2022;38:355–64. https://doi.org/10.1016/j.cjca. 2021.12.008 809. Yu J, Qiao E, Wang W. Mechanical or biologic prostheses for mitral valve replacement: a systematic review and meta-analysis. Clin Cardiol 2022;45:701–16. https://doi.org/10. 1002/clc.23854 810. Yanagawa B, Lee J, Ouzounian M, Bagai A, Cheema A, Verma S, et al. Mitral valve prosthesis choice in patients <70 years: a systematic review and meta-analysis of 20 219 patients. J Card Surg 2020;35:818–25. https://doi.org/10.1111/jocs.14478 811. Ahmed A, Awad AK, Varghese KS, Sehgal VS, Hisham K, George J, et al. Bioprosthetic versus mechanical valves for mitral valve replacement in patients <70 years: an updated pairwise meta-analysis. Gen Thorac Cardiovasc Surg 2024;72:95–103. https:// doi.org/10.1007/s11748-023-01956-1 812. Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017;38:3382–90. https://doi. org/10.1093/eurheartj/ehx303 813. Meskin M, Dimasi A, Votta E, Jaworek M, Fusini L, Muratori M, et al. A novel multiparametric score for the detection and grading of prosthetic mitral valve obstruction in cases with different disc motion abnormalities. Ultrasound Med Biol 2019;45: 1708–20. https://doi.org/10.1016/j.ultrasmedbio.2019.03.011 814. Passaglia LG, de Barros GM, de Sousa MR. Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis. J Thromb Haemost 2015;13:1557–67. https://doi.org/10.1111/jth. 13047 815. Li BX, Liu SD, Qi L, Sun S, Sun W, Li YM, et al. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients —a prospective cohort study. J Cardiothorac Surg 2020;15:40. https://doi.org/10.1186/ s13019-020-1084-7 816. Tao E, Luo YL, Tao Z, Wan L. A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin. Medicine (Baltimore) 2020;99:e18729. https:// doi.org/10.1097/MD.0000000000018729 817. Baudet EM, Puel V, McBride JT, Grimaud JP, Roques F, Clerc F, et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995; 109:858–70. https://doi.org/10.1016/s0022-5223(95)70309-8 ESC Guidelines 4731 Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026